Dissemin is shutting down on January 1st, 2025

Published in

BMJ Publishing Group, Open Heart, 1(1), p. e000023, 2014

DOI: 10.1136/openhrt-2013-000023

Links

Tools

Export citation

Search in Google Scholar

Feasibility and outcomes of ajmaline provocation testing for Brugada syndrome in children in a specialist paediatric inherited cardiovascular diseases centre.

Journal article published in 2014 by Mr R. McMillan, Tg G. Day, Margarita Bartsota, Sarah Mead-Regan, Rory Bryant, Jasveer Mangat, Dominic Abrams ORCID, Martin Lowe, Jp P. Kaski ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Brugada syndrome (BrS) is an inherited arrhythmia syndrome that causes sudden cardiac death in the young. The class Ia antiarrhythmic ajmaline can be used to provoke the diagnostic ECG pattern. Its use has been established in adults, but little data exist on the ajmaline provocation test in children. This study aims to determine the safety and feasibility of ajmaline provocation testing in a large paediatric cohort in a specialist paediatric inherited cardiac diseases centre.